A startup that wants to use [patented, synthetic & non-visionary] psychedelics to treat addiction
A new company… just raised $6.2 million to try to make psychedelics without their characteristic hallucinogenic qualities, so that the compounds can be used in medicines for diseases like addiction. Based in the US and Canada, MindMed’s team of 11 is scattered across Toronto, New York, and San Francisco. The company’s first goal is getting…
Recent Comments